What a treatment is, who regulates it, and what to ask. 222 articles, newest first.
Phentermine is a Schedule IV sympathomimetic labeled as short-term adjunct therapy, while FDA-approved GLP-1 or dual-incretin weight-management products have product-specific chronic-use labels. They differ in mechanism, route, contraindications, monitoring, continuity, cost, and evidence—not just speed or price.
Round and anatomical implants differ in geometry and orientation behavior, but shape does not determine fill, surface, profile, dimensions, pocket, or surgical result by itself. Compare the exact implant models and the anatomy-based plan rather than treating teardrop and natural as synonyms.
Zepbound has an FDA-approved obstructive-sleep-apnea indication for a defined group of adults with obesity, but it does not diagnose OSA or automatically replace PAP. The useful plan connects the exact drug label, weight-management care, sleep testing, current therapy, symptoms, and repeat assessment.
Home and office RF can share an energy family without sharing intended use, exposure, controls, endpoint, operator, or evidence. A home-use clearance applies to one named device and label; it does not make consumer RF equivalent to professional surface RF or RF microneedling.
Breast implant revision is the umbrella operation; exchange replaces an implant, while explant removes it without automatic replacement. Any pathway may also include capsule work, pocket repair, lift, fat grafting, scar revision, tissue removal, or reconstruction.
An excisional buttock lift removes and repositions loose skin and tissue; a Brazilian butt lift uses liposuction and fat grafting to add or redistribute volume. One does not substitute for the other when the primary problem is different.
Canthopexy reinforces the lateral eyelid corner; canthoplasty more structurally releases and reconstructs or repositions it; blepharoplasty changes eyelid skin, fat, and related tissues. They can be alternatives or combined components, depending on lid position, support, eye surface, and goals.
FUE describes how follicular units are excised from the donor area. DHI commonly describes immediate placement with a sharp implanter in the recipient area. A clinic can use both in one operation, so they are not competing full-procedure categories.
Endoscopic sleeve gastroplasty reduces stomach volume with full-thickness sutures placed through the mouth; sleeve gastrectomy surgically removes most of the stomach. They differ in anatomy, eligibility, evidence, risks, reversibility, follow-up, coverage, and rescue options.
Endoscopic and open brow lifts are access families, not a simple minimally invasive versus durable ranking. Compare the brow region, forehead and hairline anatomy, incision, release, fixation, muscle work, scar and sensory tradeoffs, evidence, and any eyelid or facial procedures.
Structural fat and microfat are used to place viable adipose parcels for volume; nanofat is more heavily processed, contains little or no intact adipocyte architecture, and is studied mainly for skin-quality applications. The labels still do not define one standardized preparation.
Festoons, lower-eyelid fat bags, tear-trough hollows, malar edema, and loose skin are not synonyms. They occupy different layers and locations, can coexist, and do not share a universal filler, laser, or surgical solution. Accurate feature mapping comes before treatment selection.
Forehead reduction advances the existing hair-bearing scalp and removes upper-forehead skin; hair transplantation redistributes follicles into a designed hairline. They differ in immediate density, scalp mobility, scars, donor supply, future hair loss, and staging—and can sometimes be combined.
Some laser or LED hair-growth caps are FDA cleared for narrowly described pattern-hair-loss populations, but clearance is device specific. It does not diagnose the cause of shedding, prove every cap works, transfer between models, or establish that light is the right first step for a particular hair-loss pattern.
Liposuction for clinically assessed lipedema and liposuction for elective contouring can use related instruments, but they begin with different diagnoses, goals, documentation, conservative-care history, anatomical maps, outcome measures, and long-term plans.
Low-dose naltrexone is an off-label dosing approach, not a distinct FDA-approved drug indication or standardized product. Verify the exact formulation, prescribed purpose, evidence, opioid screen, compounding record, and follow-up plan.
Lower-eyelid fat can be selectively removed, left in place, repositioned on a pedicle, or supplemented with grafted fat. First distinguish a true fat bulge from a tear-trough hollow, edema, festoon, skin change, lid laxity, and midface anatomy.
Micro-coring removes tiny full-thickness columns of skin without thermal energy; microneedling creates punctures without intentionally removing cores; laser resurfacing delivers controlled optical energy to tissue. Their mechanisms, endpoints, downtime, evidence, and device records are not interchangeable.
A Myers cocktail is not one standardized FDA-approved drug. Formulas, compounders, concentrations, sterility controls, claims, and evidence vary. The September 2026 recall applies to specified Centric Compounding lots—not to every Myers cocktail.
Septoplasty changes a deviated septum; nasal valve repair targets narrowing or collapse at the internal or external nasal valve. The procedures can be complementary, but a septoplasty alone does not automatically correct valve dysfunction.
Open and closed neck lifts describe access, not one standardized pair of operations. Open access generally adds a submental incision; closed access works without it. The decisive comparison is the actual skin, fat, platysma, gland, digastric, fixation, and facelift plan.
Oral rehydration solution is often effective when drinking is possible and the situation is appropriate; IV fluid is used when severity or another clinical factor requires venous access and monitoring. IV is not automatically better hydration, and ORS is not the same as water or a sports drink.
Picosecond and Q-switched lasers deliver very short pulses, but pulse duration alone does not decide tattoo clearance. Wavelength, pigment chemistry and depth, fluence, spot size, skin type, prior response, endpoint, interval, and the exact device matter together.
Septal, ear, autologous rib, and donor rib cartilage differ in shape, available volume, strength, donor-site burden, processing, and long-term evidence. The best source depends on the graft job and the patient's anatomy—not a universal material ranking.
Rib remodeling, partial rib resection, liposuction, and abdominoplasty target different structures. Remodeling changes rib shape without removing the full segment; current evidence is mostly selected short-term series and does not establish universal safety, permanence, or superiority.
Microneedling creates mechanical channels; fractional lasers create columns of thermal or ablative injury. Evidence for stretch marks depends on whether striae are red or white, the body site, skin type, exact laser, needling method, endpoint, sessions, pigment risk, and follow-up.
The Allurion balloon became the first FDA-approved swallowable, self-emptying intragastric balloon in February 2026. It still requires clinician placement steps, imaging confirmation, lifestyle care, follow-up, and rescue capability; it is not interchangeable with endoscopically placed and removed systems.
Temple filler is not approved as a category. FDA approval belongs to a named product, a defined indication, an age range, an injection plane, and its labeling; a March 2026 supplement added temple hollowing for one Restylane product, not every filler or every temple technique.
Trim labiaplasty removes tissue along the labial edge; a central-wedge design removes a segment while preserving more of the native edge. Neither is universally superior, and each label still leaves anatomy, extent, tension, sensation, function, scars, and revision planning undefined.
A bra-line back lift usually targets a horizontal roll or loose skin across the upper back; “upper-body lift” may describe a broader combination involving the back, lateral chest, breast, or arm junctions. Neither label defines the scar or complete operation by itself.
An FDA-cleared microcurrent device is cleared only for the named model and intended use in its decision record. Facial or neck stimulation clearance does not automatically cover a later device, conductive gel, or claims about lifting, collagen, acne, pigmentation, lymphatic drainage, or the microbiome.
BOTOX for chronic migraine and BOTOX Cosmetic contain onabotulinumtoxinA but follow different labeled purposes and protocols. Verify the product, indication, dose map, clinician, outcome records, and coverage pathway instead of comparing only a price per unit.
BOTOX Cosmetic is FDA approved for temporary improvement of moderate to severe platysma bands associated with platysma activity in adults. That product-specific indication does not make every toxin, neck line, lax-skin concern, submental treatment, or “Nefertiti lift” claim on-label.
A one-stage augmentation-mastopexy adds volume and reshapes the breast envelope in one operation. A staged plan separates those jobs so position, healing, or implant choice can be reassessed. Compare skin and tissue, nipple position, volume, device plan, recovery, total burden, and revision tolerance.
A surgical brow lift repositions brow and forehead tissues through incisions and fixation. A Botox “brow lift” is an off-label injection strategy that temporarily changes muscle balance; it cannot remove skin or reproduce fixation. Compare brow position, eyelid findings, muscle behavior, hairline, and desired change.
FDA's 2025 advisory-panel materials identified adverse-event reports and published cases of bone resorption after some supraperiosteal hyaluronic-acid filler injections. The evidence is a safety signal, not a measured population incidence or proof that all fillers, planes, areas, durations, or patients cause bone loss.
CO2 and erbium:YAG are ablative laser families, not complete treatment plans. Compare the exact device and clearance, fractional or full-field delivery, settings, passes, endpoint, skin characteristics, anesthesia, aftercare, and operator experience—not generic promises that one wavelength is deeper or gentler.
A standard tummy tuck uses a horizontal lower-abdominal pattern and advances tissue vertically; a fleur-de-lis design adds a vertical midline excision for substantial side-to-side and upper-central excess. The added vector can improve contour but creates a permanent vertical scar and T-junction.
“Microdosing” is not a standardized FDA label term, pen clicks are not a universal dose unit, and syringe units measure volume rather than drug mass. Verify the product, concentration, prescribed milligrams, corresponding volume, device, and written directions without reverse-engineering conversions.
Conventional liposuction reduces selected subcutaneous fat; high-definition liposuction adds deliberate superficial and deep contouring around underlying anatomy, sometimes with fat addition or energy-assisted steps. “HD” is not an FDA device class or proof of etched muscle, skin tightening, or superior safety.
A mini tummy tuck generally addresses a limited lower-abdominal zone; a full abdominoplasty reaches more broadly and commonly includes navel work and a wider wall-repair decision. Neither label is standardized enough to book from alone. Compare skin, fascia, fat, navel, scar, anesthesia, and recovery.
Paradoxical adipose hyperplasia is a recognized delayed cryolipolysis complication in which treated fat enlarges instead of shrinking, often forming a firm contour months later that does not resolve on its own. It differs from early swelling, incomplete reduction, weight change, or another mass.
Preservation rhinoplasty generally keeps more native dorsal structure while changing height; structural rhinoplasty more often reduces and reconstructs components with sutures or grafts. Neither name defines the incision, tip, airway work, candidacy, or result, and many operations combine both.
SARMs marketed for muscle or performance are not FDA-approved drugs and cannot lawfully be sold as dietary supplements. Prescription testosterone products have specific approved indications. A bodybuilding supplement may contain supplement ingredients, an undeclared drug, or a mislabeled SARM.
Sliding genioplasty cuts and repositions a person's chin bone with fixation; a chin implant adds a shaped permanent device over the skeleton. Compare skeletal geometry, movement needed, bite and airway context, soft tissue, device tolerance, scars, recovery, and revision options.
No testosterone product is FDA approved specifically to treat female sexual dysfunction in the United States. Off-label prescribing and patient-specific compounding are separate pathways with different evidence, labeling, quality, dosing, and monitoring records.
Injecting botulinum toxin into the trapezius for cosmetic shoulder or neck contour—often called “TrapTox”—is not an FDA-approved BOTOX Cosmetic indication. Evidence is early and protocols vary. Verify the exact product, off-label purpose, dose map, functional baseline, tradeoffs, and follow-up.
Several hyaluronic-acid fillers have product-specific FDA approvals for defined infraorbital volume deficits in adults. Approval applies to the named formulation, age, anatomy, plane, labeling, and technique—not every filler, tear trough, eyelid, orbital area, injection plane, or patient.
